Philip Tagari, Chief Scientific Officer of insitro, joins Vijay Pande, founding general partner at a16z Bio + Health.
Together, they discuss the transformative power of drugs in changing human health—and history. They also reflect on the evolution of the drug discovery process as it shifts from serendipitous discovery to AI-enabled engineering. Finally, they chat about where the industry is headed, and how AI might change the competition landscape.
The Path of a Healthtech CTO with Margaret McKenna
The AI-Flipped Clinic with Zak Kohane
Putting the Pro in Provider Networks with Dan Rosenthal
The Exec Hiring Playbook with Ben Horowitz and Ali Ghodsi
Drugging the Undruggable with Greg Verdine
Forecasting Human Health with Jeffrey Kaditz
Will AI Kill Us All? with Marc Andreessen
AI, Innovation, and Regulatory Insights with Amy Abernethy
From Faculty to Founder: Building Startups from Academia
Curing the Trust Problem with Mark Cuban
The Founders Reinventing Healthcare with Fintech
Adapting Biopharma to AI with Greg Meyers
Healthcare x Fintech with Julie Yoo and David Haber
Journal Club: Engineering Logic into CAR T Therapies with Robbie Majzner
The Future of Cheese with Magi Richani
Reengineering Healthcare and Medicine with Technology with Vineeta Agarwala
Bio x American Dynamism with Katherine Boyle and David Ulevitch
Shaping Channel Partnerships with Sean Duffy
Strategizing Channel Partnerships with Florian Otto
AI and Actionable Insights for Drug Development with Daphne Koller
Create your
podcast in
minutes
It is Free